Evidence map›Paper›PMID 32895776›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Discovery of specific mutations in spinal muscular atrophy patients by next-generation sequencing.

Yu-Lian Fang, Na Li, Xiu-Fang Zhi, Jie Zheng, Yang Liu, Lin-Jie Pu, Chun-Yu Gu, Jian-Bo Shu, Chun-Quan Cai

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu-Lian Fang *Institute of Pediatrics, Tianjin Children's Hospital, 238 Longyan Road, Beichen District, Tianjin, 300134, China.
Na Li *Department of Neonatology, The Pediatric Clinical College, Tianjin Medical University, Tianjin, 300134, China.
Xiu-Fang Zhi *Graduate School, Tianjin Medical University, Tianjin, 300070, China.
Jie Zheng *Graduate School, Tianjin Medical University, Tianjin, 300070, China.
Yang LiuDepartment of Neonatology, The Pediatric Clinical College, Tianjin Medical University, Tianjin, 300134, China.
Lin-Jie PuGraduate School, Tianjin Medical University, Tianjin, 300070, China.
Chun-Yu GuGraduate School, Tianjin Medical University, Tianjin, 300070, China.
Jian-Bo ShuInstitute of Pediatrics, Tianjin Children's Hospital, 238 Longyan Road, Beichen District, Tianjin, 300134, China. jianboshu1981@sina.com.
Chun-Quan CaiInstitute of Pediatrics, Tianjin Children's Hospital, 238 Longyan Road, Beichen District, Tianjin, 300134, China. caichunquanccq@163.com.ORCID http://orcid.org/0000-0001-9784-5250

Funding

National Natural Science Foundation of China 81771589the Key Project of Tianjin Health Care Professionals 16KG166the Program of Tianjin Science and Technology Plan 18ZXDBSY00170
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is a type of autosomal recessive genetic disease, which seriously threatens the health and lives of children and adolescents. We attempted to find some genes and mutations related to the onset of SMA. Eighty-three whole-blood samples were collected from 28 core families, including 28 probands with clinically suspected SMA (20 SMA patients, 5 non-SMA children, and 3 patients with unknown etiology) and their parents. The multiplex ligation probe amplification (MLPA) was performed for preliminary diagnosis. The high-throughput sequencing technology was used to conduct the whole-exome sequencing analysis. We analyzed the mutations in adjacent genes of SMN1 gene and the unique mutations that only occurred in SMA patients. According to the MLPA results, 20 probands were regarded as experimental group and 5 non-SMA children as control group. A total of 10 mutations were identified in the adjacent genes of SMN1 gene. GUSBP1 g.[69515863G>A], GUSBP1 g.[69515870C>T], and SMA4 g.[69515738C>A] were the top three most frequent sites. SMA4 g.[69515726A>G] and OCLN c.[818G>T] have not been reported in the existing relevant researches. Seventeen point mutations in the DYNC1H1 gene were only recognized in SMA children, and the top two most common mutations were c.[2869-34A>T] and c.[345-89A>G]; c.[7473+105C>T] was the splicing mutation that might change the mRNA splicing site. The mutations of SMA4 g.[69515726A>G], OCLN c.[818G>T], DYNC1H1 c.[2869-34A>T], DYNC1H1 c.[345-89A>G], and DYNC1H1 c.[7473+105C>T] in the adjacent genes of SMN1 gene and other genes might be related to the onset of SMA.

Indexed as

Muscular Atrophy, SpinalAdolescentChildHigh-Throughput Nucleotide SequencingHumansMutationParentsPoint MutationSurvival of Motor Neuron 1 ProteinSurvival of Motor Neuron 1 ProteinDYNC1H1High-throughput sequencingOCLNSMA4Spinal muscular atrophy (SMA)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.